Physician profile
Juan Campos
NPI 1417042136
$528.78
in general payments reported to CMS, 2019-2025
19 companies · $83.05 in 2025
The $83.05 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $85.43 · 2021: $12.88 · 2022: $72.46 · 2023: $36.07 · 2024: $116 · 2025: $83.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $235.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $77.29 | 2019-2020 | |
| Solventum Corporation | $60.27 | 2024-2025 | Activ.A.C. |
| Abbvie INC. | $58.70 | 2021-2025 | |
| Kerecis Limited | $38.03 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Melinta Therapeutics, LLC | $36.12 | 2019-2020 | |
| Leica Microsystems INC. | $32.02 | 2020 | |
| Innocoll Pharmaceuticals Limited | $28.91 | 2022 | |
| Mentor Worldwide LLC | $25.10 | 2024 | Artoura Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Janssen Biotech, INC. | $19.96 | 2022 | |
| Paratek Pharmaceuticals, INC. | $18.83 | 2023 | Nuzyra |
| Acera Surgical, INC. | $18.16 | 2019 | |
| Davol INC. | $17.53 | 2019 | |
| Tela Bio, INC. | $17.24 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $15.65 | 2024 | Echelon; Endopath |
| Medtronic, INC. | $14.33 | 2024 | Absorbatack |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $13.90 | 2019 | |
| Integra Lifesciences Corporation | $13.15 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.18 | 2022 | |
| Polynovo North America LLC | $11.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Campos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.